Cargando…
Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence
Despite decades of intensive basic and clinical research efforts, there is still no successful vaccine candidate against human immunodeficiency virus (HIV-1). Standard combined antiretroviral therapy (cART) has been successfully developed and has given remarkable results suppressing HIV-1 infection...
Autores principales: | Weichseldorfer, Matthew, Heredia, Alonso, Reitz, Marvin, Bryant, Joseph L., Latinovic, Olga S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250391/ https://www.ncbi.nlm.nih.gov/pubmed/32457941 |
Ejemplares similares
-
Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
por: Weichseldorfer, Matthew, et al.
Publicado: (2021) -
CCR5 Inhibitors and HIV-1 Infection
por: Latinovic, Olga S., et al.
Publicado: (2019) -
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies
por: Weichseldorfer, Matthew, et al.
Publicado: (2022) -
Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice
por: Weichseldorfer, Matthew, et al.
Publicado: (2021) -
A novel small-molecule inhibitor of HIV-1 entry
por: Heredia, Alonso, et al.
Publicado: (2015)